We are live on ! Find out more
NIP

Nicholas Investment Partners Portfolio holdings

AUM $1.39B
1-Year Est. Return 97.11%
This Fund
S&P 500
This Quarter Est. Return
-3.02%
1 Year Est. Return
+97.11%
3 Year Est. Return
+361.61%
5 Year Est. Return
+496.81%
10 Year Est. Return
+3,647.69%
AUM
$1.41B
AUM Growth
-$175M
Cap. Flow
-$69.4M
Cap. Flow %
-4.94%
Top 10 Hldgs %
19.17%
Holding
227
New
39
Increased
75
Reduced
46
Closed
36

Top Buys

Rank Stock Value
1
HQY icon
HealthEquity
HQY
+$17M
2
BROS icon
Dutch Bros
BROS
+$13.9M
3
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$13.1M
4
INSP icon
Inspire Medical Systems
INSP
+$13M
5
ALBO
Albireo Pharma Inc
ALBO
+$12.9M

Top Sells

Rank Stock Value
1
WAL icon
Western Alliance Bancorporation
WAL
+$24.1M
2
ARNA
Arena Pharmaceuticals Inc
ARNA
+$22.2M
3
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
+$18.8M
4
KTB icon
Kontoor Brands
KTB
+$16.2M
5
NEO icon
NeoGenomics
NEO
+$14.6M

Sector Composition

Rank Sector Weight
1 Healthcare 36.56%
2 Technology 16.86%
3 Financials 8.72%
4 Energy 7.73%
5 Industrials 6.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ITCI
1
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$34.4M 2.45%
562,373
-90,513
-14% -$4.7M
EXE
2
Expand Energy Corp
EXE
$21.9B
$30.5M 2.17%
351,058
+41,071
+13% +$3.01M
ARGX icon
3
argenx
ARGX
$52B
$30.4M 2.16%
96,360
+20,928
+28% +$6.09M
MPWR icon
4
Monolithic Power Systems
MPWR
$66B
$27.6M 1.97%
56,920
-10,088
-15% -$4.4M
ESI icon
5
Element Solutions
ESI
$9.18B
$25.4M 1.8%
1,157,699
+257,092
+29% +$5.92M
HZNP
6
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$25.2M 1.8%
239,925
+78,862
+49% +$7.69M
PODD icon
7
Insulet
PODD
$11.8B
$25.1M 1.78%
94,094
+31,506
+50% +$7.73M
LSCC icon
8
Lattice Semiconductor
LSCC
$18B
$24.1M 1.71%
394,818
-44,449
-10% -$2.67M
WSC icon
9
WillScot Mobile Mini Holdings
WSC
$4.66B
$24M 1.71%
614,426
+33,206
+6% +$1.25M
ESTA icon
10
Establishment Labs
ESTA
$2.73B
$22.7M 1.61%
336,392
+86,728
+35% +$5.07M
RGEN icon
11
Repligen
RGEN
$8.3B
$22M 1.57%
116,987
+19,235
+20% +$3.65M
ASND icon
12
Ascendis Pharma A/S
ASND
$16B
$22M 1.56%
187,401
+75,279
+67% +$8.72M
BILL icon
13
BILL Holdings
BILL
$4.7B
$21.8M 1.55%
96,099
+28,186
+42% +$5.88M
HQY icon
14
HealthEquity
HQY
$8.72B
$21.2M 1.51%
+314,704
New +$17M
AVTR icon
15
Avantor
AVTR
$9.25B
$21.1M 1.5%
623,834
+76,860
+14% +$2.74M
BHVN
16
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$20.9M 1.49%
176,283
-50,588
-22% -$6.31M
NARI
17
DELISTED
Inari Medical, Inc. Common Stock
NARI
$20M 1.43%
221,175
+116,243
+111% +$9.51M
MSFT icon
18
Microsoft
MSFT
$3.62T
$19M 1.36%
61,781
+17,530
+40% +$5.27M
TFII icon
19
TFI International
TFII
$11.1B
$18.8M 1.33%
176,090
+8,869
+5% +$903K
ISEE
20
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$18.4M 1.31%
1,093,676
+553,946
+103% +$8.19M
CVX icon
21
Chevron
CVX
$385B
$18.2M 1.29%
111,700
+200
+0.2% +$28.7K
XOM icon
22
ExxonMobil
XOM
$643B
$17.6M 1.26%
213,710
+1,735
+0.8% +$135K
RRR icon
23
Red Rock Resorts
RRR
$3.84B
$17.2M 1.23%
355,171
+46,938
+15% +$2.24M
VRTX icon
24
Vertex Pharmaceuticals
VRTX
$119B
$16.2M 1.15%
62,069
+23,782
+62% +$5.64M
PACW
25
DELISTED
PacWest Bancorp
PACW
$16.1M 1.15%
373,456
+124,953
+50% +$5.9M
1
2 3 4 5

Similar funds

FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
1CP
1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return
OCM
Opti Capital Management New York $1.39B AUM 0% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
TA
Trivest Advisors Hong Kong $1.39B AUM 273.03% 1-Year Est. Return
AU
Algebris (UK) London, United Kingdom $1.38B AUM 3.87% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
BCP
Blue Chip Partners Farmington Hills, Michigan $1.39B AUM 22.32% 1-Year Est. Return

Nicholas Investment Partners's Q1 2022 Portfolio in Review

As of Q1 2022, Nicholas Investment Partners held 227 positions worth $1.41B, down 11% from $1.58B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Nicholas Investment Partners withdrew a net $69.4M in Q1 2022, closing 36 positions and reducing 46 holdings. Its most notable exit was Western Alliance Bancorporation, an estimated $24.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 37% of assets, up from 30% a quarter earlier, followed by Technology and Financials.

Against the trend, Nicholas Investment Partners opened a new position in HealthEquity worth $21.2M.

  • Nicholas Investment Partners's largest Q1 2022 buy was HealthEquity: 314,704 shares worth $21.2M.
  • Nicholas Investment Partners added most to Inari Medical, Inc. Common Stock in Q1 2022, an estimated $9.51M increase.
  • Nicholas Investment Partners's biggest Q1 2022 reduction was Chart Industries, cutting an estimated $14.2M.
  • Nicholas Investment Partners fully exited Western Alliance Bancorporation in Q1 2022, selling an estimated $24.1M.
  • Nicholas Investment Partners's ten largest holdings make up 19% of its $1.41B portfolio in Q1 2022.
  • Nicholas Investment Partners opened 39 new positions and closed 36 in Q1 2022.
  • Nicholas Investment Partners's portfolio value fell 11% quarter-over-quarter to $1.41B.

Based on Nicholas Investment Partners's 13F filing for Q1 2022, filed 10 May 2022.